Mount Sinai Researchers Find That Tranexamic Acid, a Blood Clotting Drug Commonly Used for Orthopedic Surgeries, Does Not Increase Complications for High-Risk Patients
Case Western Reserve University researchers who developed a portable sensor to assess the clotting ability of a person’s blood are working with the U.S. Navy to develop a rugged version of the device to detect problems with blood coagulation in cases of traumatic injury and preserve critical blood supplies.
COVID-19 may increase the risk of blot cots in women who are pregnant or taking estrogen with birth control or hormone replacement therapy, according to a new manuscript published in the Endocrine Society’s journal, Endocrinology.
New findings led by Yale Cancer Center researchers and experts across several medical specialties at Yale identify a leading mechanism behind the pathophysiology of Covid-19 and pinpoint a biological marker for the mechanism that may aid in treating these patients.
A new review suggests that higher-than-normal levels of an enzyme involved in blood clot prevention may be a common risk factor for developing COVID-19—a respiratory disease caused by the novel coronavirus SARS-CoV-2—in some populations. The review is published in Physiological Reviews.
Inspired by their use in mechanical systems, Massachusetts Institute of Technology researchers are testing a magnetically-actuated fluidic valve to use in trauma patients suffering from hemorrhage.